[
link to www.medalerts.org (secure)]
From the 7/30/2021 release of VAERS data:
[x] expert mode
table
Manufacture
Symptoms SMQ Broad.
JANSSEN
Accidents and injuries 27 0.04%
Acute central respiratory depression 651 0.93%
Acute pancreatitis 549 0.78%
Acute renal failure 39 0.06%
Agranulocytosis 6 0.01%
Akathisia 33 0.05%
Anaphylactic/anaphylactoid shock conditions 111 0.16%
Anaphylactic reaction 895 1.28%
Angioedema 286 0.41%
Anticholinergic syndrome 1,171 1.67%
Arrhythmia related investigations, signs and sy... 521 0.74%
Arthritis 260 0.37%
Asthma/bronchospasm 86 0.12%
Biliary system related investigations, signs an... 8 0.01%
Cardiac failure 173 0.25%
Cardiomyopathy 1,146 1.63%
Cholestasis and jaundice of hepatic origin 1 0%
Chronic kidney disease 125 0.18%
Conditions associated with central nervous syst... 189 0.27%
Congenital and neonatal arrhythmias 1 0%
Convulsions 7 0.01%
Corneal disorders 35 0.05%
COVID-19 182 0.26%
Dehydration 275 0.39%
Dementia 425 0.61%
Demyelination 2 0%
Depression (excl suicide and self injury) 68 0.1%
Drug abuse and dependence 18 0.03%
Drug reaction with eosinophilia and systemic sy... 1,166 1.66%
Dyskinesia 45 0.06%
Dystonia 198 0.28%
Eosinophilic pneumonia 414 0.59%
Extravasation events (injections, infusions and... 200 0.29%
Fertility disorders 4 0.01%
Gastrointestinal nonspecific dysfunction 1 0%
Gastrointestinal nonspecific inflammation 8 0.01%
Gastrointestinal nonspecific symptoms and thera... 271 0.39%
Gastrointestinal perforation, ulcer, haemorrhag... 28 0.04%
Generalised convulsive seizures following immun... 94 0.13%
Glaucoma 197 0.28%
Guillain-Barre syndrome 902 1.29%
Haematopoietic cytopenias affecting more than o... 6 0.01%
Haematopoietic erythropenia 54 0.08%
Haematopoietic leukopenia 26 0.04%
Haematopoietic thrombocytopenia 4 0.01%
Haemorrhage laboratory terms 185 0.26%
Hearing impairment 114 0.16%
Hepatic failure, fibrosis and cirrhosis and oth... 2 0%
Hostility/aggression 43 0.06%
Hyperglycaemia/new onset diabetes mellitus 248 0.35%
Hypersensitivity 194 0.28%
Hypertension 5 0.01%
Hyperthyroidism 12 0.02%
Hypoglycaemia 813 1.16%
Hypoglycaemic and neurogenic shock conditions 111 0.16%
Hypokalaemia 109 0.16%
Hyponatraemia/SIADH 18 0.03%
Hypothyroidism 13 0.02%
Hypotonic-hyporesponsive episode 311 0.44%
Hypovolaemic shock conditions 111 0.16%
Immune-mediated/autoimmune disorders 193 0.28%
Infective pneumonia 393 0.56%
Interstitial lung disease 13 0.02%
Ischaemic colitis 44 0.06%
Lactic acidosis 16 0.02%
Lens disorders 141 0.2%
Lipodystrophy 19 0.03%
Liver related investigations, signs and symptoms 4 0.01%
Malignant lymphomas 6 0.01%
Medication errors 6 0.01%
Myelodysplastic syndrome 12 0.02%
Myocardial infarction 31 0.04%
Neonatal disorders 4 0.01%
Neuroleptic malignant syndrome 1,074 1.53%
Noninfectious diarrhoea 28 0.04%
Noninfectious encephalitis 778 1.11%
Noninfectious encephalopathy/delirium 740 1.06%
Noninfectious meningitis 613 0.87%
Ocular infections 7 0.01%
Ocular motility disorders 17 0.02%
Opportunistic infections 398 0.57%
Optic nerve disorders 119 0.17%
Osteonecrosis 31 0.04%
Osteoporosis/osteopenia 13 0.02%
Other ischaemic heart disease 15 0.02%
Parkinson-like events 274 0.39%
Peripheral neuropathy 394 0.56%
Proteinuria 2 0%
Pseudomembranous colitis 131 0.19%
Psychosis and psychotic disorders 62 0.09%
Pulmonary hypertension 613 0.87%
Renovascular disorders 9 0.01%
Respiratory failure 232 0.33%
Retinal disorders 176 0.25%
Retroperitoneal fibrosis 297 0.42%
Rhabdomyolysis/myopathy 430 0.61%
Sepsis 24 0.03%
Severe cutaneous adverse reactions 15 0.02%
Shock-associated circulatory or cardiac conditi... 99 0.14%
Skin tumours of unspecified malignancy 2 0%
Systemic lupus erythematosus 387 0.55%
Tendinopathies and ligament disorders 568 0.81%
Thrombophlebitis 498 0.71%
Torsade de pointes, shock-associated conditions 118 0.17%
Torsade de pointes/QT prolongation 269 0.38%
Toxic-septic shock conditions 106 0.15%
Tubulointerstitial diseases 29 0.04%
Tumour lysis syndrome 109 0.16%
Uterine and fallopian tube malignant tumours 1 0%
Uterine and fallopian tube tumours of unspecifi... 2 0%
Vasculitis 2 0%
Vestibular disorders 333 0.48%
total 23,094 32.94%